These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8163759)

  • 1. Clinical use of ganciclovir during renal failure and continuous hemodialysis.
    Bastien O; Boulieu R; Bleyzac N; Estanove S
    Intensive Care Med; 1994; 20(1):47-8. PubMed ID: 8163759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ganciclovir in heart transplant patients undergoing continuous venovenous hemodialysis.
    Boulieu R; Bastien O; Bleyzac N
    Ther Drug Monit; 1993 Apr; 15(2):105-7. PubMed ID: 8389067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ganciclovir in a patient undergoing hemodialysis.
    Swan SK; Munar MY; Wigger MA; Bennett WM
    Am J Kidney Dis; 1991 Jan; 17(1):69-72. PubMed ID: 1846060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipients.
    Perrottet N; Robatel C; Meylan P; Pascual M; Venetz JP; Aubert JD; Berger MM; Decosterd LA; Buclin T
    J Antimicrob Chemother; 2008 Jun; 61(6):1332-5. PubMed ID: 18344549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of valganciclovir and ganciclovir in renal impairment.
    Czock D; Scholle C; Rasche FM; Schaarschmidt D; Keller F
    Clin Pharmacol Ther; 2002 Aug; 72(2):142-50. PubMed ID: 12189361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ganciclovir in renal transplant children.
    Jacqz-Aigrain E; Macher MA; Sauvageon-Marthe H; Brun P; Loirat C
    Pediatr Nephrol; 1992 Mar; 6(2):194-6. PubMed ID: 1315149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ganciclovir in a patient undergoing chronic haemodialysis.
    Combarnous F; Fouque D; Bernard N; Boulieu R; Chossegros P; Laville M; Zech P
    Eur J Clin Pharmacol; 1994; 46(4):379-81. PubMed ID: 7957527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low plasma concentrations achieved with conventional schedules of administration of ganciclovir in patients with AIDS.
    Piketty C; Bardin C; Gilquin J; Mahe V; Kazatchkine MD; Chast F
    J Infect Dis; 1996 Jul; 174(1):188-90. PubMed ID: 8655992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral ganciclovir dosing in transplant recipients and dialysis patients based on renal function.
    Pescovitz MD; Pruett TL; Gonwa T; Brook B; McGory R; Wicker K; Griffy K; Robinson CA; Jung D
    Transplantation; 1998 Oct; 66(8):1104-7. PubMed ID: 9808499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma pharmacokinetics of daptomycin in critically ill patients with renal failure and undergoing CVVHD.
    Khadzhynov D; Slowinski T; Lieker I; Spies C; Puhlmann B; König T; Uhrig A; Eggers K; Neumayer HH; Traunmüller F; Joukhadar C; Peters H
    Int J Clin Pharmacol Ther; 2011 Nov; 49(11):656-65. PubMed ID: 22011690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of mezlocillin and sulbactam under continuous veno-venous hemodialysis (CVVHD) in intensive care patients with acute renal failure.
    Rohde B; Werner U; Hickstein H; Ehmcke H; Drewelow B
    Eur J Clin Pharmacol; 1997; 53(2):111-5. PubMed ID: 9403281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of ganciclovir in pediatric renal transplant recipients.
    Zhang D; Lapeyraque AL; Popon M; Loirat C; Jacqz-Aigrain E
    Pediatr Nephrol; 2003 Sep; 18(9):943-8. PubMed ID: 12883977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ganciclovir during continuous venovenous hemodiafiltration in critically ill patients.
    Horvatits T; Kitzberger R; Drolz A; Zauner C; Jäger W; Böhmdorfer M; Kraff S; Fritsch A; Thalhammer F; Fuhrmann V; Schenk P
    Antimicrob Agents Chemother; 2014; 58(1):94-101. PubMed ID: 24145543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study.
    Hochster H; Dieterich D; Bozzette S; Reichman RC; Connor JD; Liebes L; Sonke RL; Spector SA; Valentine F; Pettinelli C
    Ann Intern Med; 1990 Jul; 113(2):111-7. PubMed ID: 2163228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosing of intravenous ganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplant recipients.
    Fishman JA; Doran MT; Volpicelli SA; Cosimi AB; Flood JG; Rubin RH
    Transplantation; 2000 Feb; 69(3):389-94. PubMed ID: 10706048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganciclovir in solid organ transplant recipients: is there a role for clinical pharmacokinetic monitoring?
    Scott JC; Partovi N; Ensom MH
    Ther Drug Monit; 2004 Feb; 26(1):68-77. PubMed ID: 14749553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and outcomes of prolonged cytomegalovirus prophylaxis to cover the enhanced immunosuppression phase following lung transplantation.
    Gerbase MW; Dubois D; Rothmeier C; Spiliopoulos A; Wunderli W; Nicod LP
    Chest; 1999 Nov; 116(5):1265-72. PubMed ID: 10559085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral ganciclovir in pediatric transplant recipients: a pharmacokinetic study.
    Pescovitz MD; Brook B; Jindal RM; Leapman SB; Milgrom ML; Filo RS
    Clin Transplant; 1997 Dec; 11(6):613-7. PubMed ID: 9408695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers.
    Brown F; Banken L; Saywell K; Arum I
    Clin Pharmacokinet; 1999 Aug; 37(2):167-76. PubMed ID: 10496303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of ganciclovir prophylaxis on cytomegalovirus infection in recipients of cadaveric renal allografts.
    Ram Peddi V; Hariharan S; Schroeder TJ; First MR
    Nephron; 1997; 76(1):49-55. PubMed ID: 9171300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.